US Patent Issued to Vertex Pharmaceuticals on Feb. 17 for "Crystalline forms of CFTR modulators" (British, American Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,810, issued on Feb. 17, was assigned to Vertex Pharmaceuticals Inc. (Boston).

"Crystalline forms of CFTR modulators" was invented by Satish Kumar Iyemperumal (Reading, Great Britain), Andrey Peresypkin (Newton, Mass.), Yi Shi (Natick, Mass.) and Muna Shrestha (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Crystalline forms of salts of Compound I are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed."

The patent was filed on Aug. 12, 2021, under Application No. 18/020,802.

*For further information, including images, chart...